Physician
Pathology
Dr. Peter C. Appelbaum, MD
|
|
Give Review
Dr. Peter C. Appelbaum practices Pathology. Peter Appelbaum is a published doctor as well. He has 101 publications published. The latest was: Antistaphylococcal Activity of Oritavancin and its Synergistic Effect in Combination with Other Antimicrobial Agents.
Publications
- Antistaphylococcal Activity of Oritavancin and its Synergistic Effect in Combination with Other Antimicrobial Agents.
- Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill.
- 2012 and beyond: potential for the start of a second pre-antibiotic era?
- Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin.
- Activity of ACHN-490 Tested Alone and in Combination with Other Agents against Pseudomonas aeruginosa.
- Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.
- In Vitro Activity of Fusidic Acid (CEM-102, Sodium Fusidate) against Staphylococcus aureus Isolates from Cystic Fibrosis Patients and Its Effect on the Activities of T...
- Time-kill activity of the streptogramin NXL 103 against Gram-positive and -negative bacteria.
- Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital.
- Mutant prevention concentrations of four carbapenems against gram-negative rods.
- Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
- Cellular pharmacodynamics of the novel biaryloxazolidinone radezolid: studies with infected phagocytic and nonphagocytic cells, using Staphylococcus aureus, Staphyloco...
- Antistaphylococcal activity of ACHN-490 tested alone and in combination with other agents by time-kill assay.
- Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
- Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.
- In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
- Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
- Resistance selection studies comparing the activity of razupenem (PTZ601) to vancomycin and linezolid against eight methicillin-resistant and two methicillin-susceptib...
- Comparative antipneumococcal activities of sulopenem and other drugs.
- Antianaerobic activity of sulopenem compared to six other agents.
- Binding of faropenem and other beta-lactam agents to penicillin-binding proteins of pneumococci with various beta-lactam susceptibilities.
- Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.
- Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.
- In vitro activity of the quinolone WCK 771 against recent U.S. hospital and community-acquired Staphylococcus aureus pathogens with various resistance types.
- Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.
- Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones.
- Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.
- Antistreptococcal activity of AR-709 compared to that of other agents.
- Activity of ceftobiprole compared with those of other agents against Staphylococcus aureus strains with different resistotypes by time-kill analysis.
- In vitro capability of faropenem to select for resistant mutants of Streptococcus pneumoniae and Haemophilus influenzae.
- Comparative antianaerobic activities of doripenem determined by MIC and time-kill analysis.
- In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci.
- Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
- Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
- Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents.
- Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies.
- Genetic characterization of erythromycin- and methicillin-resistant community-acquired Staphylococcus aureus isolated from children in Texas.
- Microbiology of antibiotic resistance in Staphylococcus aureus.
- Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.
- Antianaerobe activity of ceftobiprole, a new broad-spectrum cephalosporin.
- Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology.
- Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.
- Antimicrobial resistance in Haemophilus influenzae.
- Multistep resistance selection and postantibiotic-effect studies of the antipneumococcal activity of LBM415 compared to other agents.
- Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis.
- Telithromycin-nonsusceptible clinical isolates of Streptococcus pneumoniae from Europe.
- Effects of various media on the activity of NXL103 (formerly XRP 2868), a new oral streptogramin, against Haemophilus influenzae.
- Activity of LBM415 compared to those of 11 other agents against Haemophilus species.
- Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
- Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.
- Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies.
- Activities of tizoxanide and nitazoxanide compared to those of five other thiazolides and three other agents against anaerobic species.
- Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.
- Single- and multistep resistance selection studies on the activity of retapamulin compared to other agents against Staphylococcus aureus and Streptococcus pyogenes.
- Two new colorimetric methods for early detection of vancomycin and oxacillin resistance in Staphylococcus aureus.
- Antipneumococcal activity of dalbavancin compared to other agents.
- Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones.
- Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin.
- A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
- Antistaphylococcal activity of DX-619, a new des-F(6)-quinolone, compared to those of other agents.
- Comparison of multiple-locus variable-number tandem-repeat analysis with pulsed-field gel electrophoresis, spa typing, and multilocus sequence typing for clonal charac...
- Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas.
- Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin.
- Are cephalosporins appropriate for the treatment of acute otitis media in this era of increasing antimicrobial resistance among common respiratory tract pathogens?
- Antistaphylococcal activity of dalbavancin, an experimental glycopeptide.
- Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models.
- Derivatives of a vancomycin-resistant Staphylococcus aureus strain isolated at Hershey Medical Center.
- Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telit...
- Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus i...
- Activity of OPT-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species.
- Antipneumococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
- Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
- Antistaphylococcal activity of CB-181963 (CAB-175), an experimental parenteral cephalosporin.
- In vitro activity of the new quinolone WCK 771 against staphylococci.
- DNA binding ligands with improved in vitro and in vivo potency against drug-resistant Staphylococcus aureus.
- Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.
- Vancomycin resistance in Staphylococcus aureus.
- Mechanisms of resistance among respiratory tract pathogens.
- Macrolide resistance in Streptococci and Haemophilus influenzae.
- Susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 17 oral antimicrobial agents based on pharmacodynamic parameters: 1998...
- In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 beta-lactams.
- Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure.
- Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania.
- Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.
- Activities of a new oral streptogramin, XRP 2868, compared to those of other agents against Streptococcus pneumoniae and haemophilus species.
- White piedra: further evidence of a synergistic infection.
- Antimicrobial susceptibility and macrolide resistance inducibility of Streptococcus pneumoniae carrying erm(A), erm(B), or mef(A).
- Time-kill studies of the antianaerobe activity of garenoxacin compared with those of nine other agents.
- Antipneumococcal and antistaphylococcal activities of ranbezolid (RBX 7644), a new oxazolidinone, compared to those of other agents.
- Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates.
- Activities of HMR 3787 and RU 64399 compared with those of four other agents against Haemophilus influenzae and Haemophilus parainfluenzae.
- Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic brea...
- Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States.
- Use of appropriate breakpoints in antimicrobial surveillance studies.
- In vitro selection of resistance in Haemophilus influenzae by amoxicillin-clavulanate, cefpodoxime, cefprozil, azithromycin, and clarithromycin.
- Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia.
- Effects of various test media on the activities of 21 antimicrobial agents against Haemophilus influenzae.
- Incidence, epidemiology, and characteristics of quinolone-nonsusceptible Streptococcus pneumoniae in Croatia.
- Maxillary sinus puncture and culture in the diagnosis of acute rhinosinusitis: the case for pursuing alternative culture methods.
- Resistance among Streptococcus pneumoniae: Implications for drug selection.
Doctors Specialties
- Medical Microbiology
- Pathology
Accepted Insurances
Helpful Reviews
Similar Doctors
|
|
Dr. Bing Han, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zhaohai Yang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer Tserng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xuebin Yang, MD
This Doctor is OpenDoctor Recommended.
|